US Stock MarketDetailed Quotes
RNAZ Transcode Therapeutics
- 1.040
- 0.0000.00%
Trading Jun 26 14:26 ET
7.56MMarket Cap0.01P/E (TTM)
1.068High1.015Low52.83KVolume1.050Open1.040Pre Close54.40KTurnover0.76%Turnover Ratio0.00P/E (Static)7.27MShares128.00052wk High1.65P/B7.20MFloat Cap0.42052wk Low--Dividend TTM6.92MShs Float5600.000Historical High--Div YieldTTM5.12%Amplitude0.420Historical Low1.029Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Transcode Therapeutics Stock Forum
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
TransCode Therapeutics (NASDAQ: RNAZ) announced positive preliminary data from its Phase 0 clinical trial for TTX-MC138, their lead RNA-based therapeutic candidate. The trial showed significant inhibition of the molecular target miRNA-10b, with a 66% reduction in the patient's blood 24 hours post-administration. This inhibition is...
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
No comment yet